Veículo
Ecancer (Reino Unido)
Em 2026: 8 notícias
Desde 1995: 43 notícias
Brazilian biobank may help personalise cancer prevention in the public health system
Publicado em 21 de outubro de 2026
A bank of biological samples from thousands of Brazilians could help the Unified Health System (SUS), which is public and free, identify people at higher risk of developing certain types of cancer.
In the future, the SUS could offer these individuals more personalised prevention and screening strategies.
Developed at Hospital de Amor in Barretos, a city in the Southeast region of Brazil, the initiative collects genetic, epidemiological, and lifestyle data from people with and without [...]
-
Unprecedented marker uses tomography to refine gastric cancer prognosis
Publicado em 17 junho 2026Researchers at the State University of Campinas (UNICAMP) in São Paulo, Brazil, have identified a new biomarker that may help determine the prognosis for patients with gastric cancer, the fifth most common type of cancer worldwide. The team identified a variable that combines data on the radiodensity of visceral fat and muscle by analysing images from computed tomography (CT) scans, a routine examination for these patients. This variable is capable of distinguishing those at higher risk [...]ver notícia -
Cracking the code of p53 fragility: Why the genome guardian is prone to failure
Publicado em 20 maio 2026The protein p53 is often called the guardian of the genome for its central role in preventing cancer. Yet paradoxically, it is also one of the most frequently mutated and dysfunctional proteins in human tumours. A longstanding mystery has been why p53 - unlike its closely related paralogs p63 and p73 - is so prone to misfolding and forming toxic aggregates. A new study published in Communication Chemistry now provides a detailed molecular explanation for this vulnerability. Led by [...]ver notícia -
Biosensor identifies pancreatic cancer in early stages
Publicado em 23 abril 2026Brazilian researchers have developed an electrochemical sensor that can detect pancreatic cancer in its early stages. The device identifies the biomarker molecule CA19-9, which is associated with the disease, at low concentrations in a patient’s blood. This offers a simpler, more affordable alternative to conventional tests, which are less accessible. “In its early stages, pancreatic cancer is asymptomatic, which means the disease is often identified too late. That’s also why [...]ver notícia -
Researchers make breakthrough in biomedical imaging and cancer treatment
Publicado em 19 março 2026The Nanomedicine and Nanotoxicology Group (GNano) at the University of São Paulo’s São Carlos Institute of Physics (IFSC-USP) in Brazil has discovered a way to transform hydroxyapatite, a bioceramic material, into a nanoparticle with enhanced intrinsic luminescence. This paves the way for the use of biocompatible, low-cost nanomaterials in biomedical imaging techniques. “We’ve demonstrated that the incorporation of carbonate groups into the hydroxyapatite structure increases the [...]ver notícia -
New strategies boost effectiveness of CAR-NK therapy against cancer
Publicado em 23 fevereiro 2026Researchers at the Ribeirão Preto Blood Centre and the Centre for Cell-Based Therapy (CTC) conducted a study using the NK-92 cell line to test new models of chimaeric antigen receptors (CARs) with specific costimulatory domains, such as 2B4 and DAP12. The tests showed that these components helped make the cells “ready to attack,” thereby increasing their ability to destroy tumours. The results were published in the journal Frontiers in Immunology. The CTC is one of the [...]ver notícia -
Artificial saliva containing sugarcane protein helps protect the teeth of patients with head and neck cancer
Publicado em 08 janeiro 2026An artificial saliva in the form of a mouthwash, produced with the CANECPI-5 protein extracted from sugarcane and modified in a laboratory, can aid in treating teeth in patients with head and neck cancer. In these cases, radiotherapy very close to the mouth can destroy salivary glands and compromise saliva production, which is essential for controlling bacteria and disease. According to research conducted at the Bauru School of Dentistry at the University of São Paulo (FOB-USP) in [...]ver notícia -
Advances in liquid biopsies as a tool for detecting lung cancer mutations
Publicado em 08 janeiro 2026In Brazil, the early detection of genetic alterations in lung cancer through liquid biopsies could be a valuable tool for expediting diagnoses and guiding patient treatment. A study supported by FAPESP and published in the journal Molecular Oncology showed that it is possible to identify relevant mutations in blood samples from patients with non-small cell lung cancer (NSCLC) using a commercial multigene panel. Conducted at Hospital de Amor de Barretos, a national oncology reference [...]ver notícia -
Study identifies candidates for therapeutic targets in paediatric germ cell tumours
Publicado em 19 setembro 2025A study conducted by the Molecular Oncology Research Centre (CPOM) at Hospital de Amor in Barretos (formerly Barretos Cancer Hospital) in the state of São Paulo, Brazil, has identified possible biomarkers that could guide the development of more personalised therapies for paediatric germ cell tumours (GCTs). Although GCTs account for only 3% of childhood cancers, they challenge doctors and researchers due to their diversity and the toxicity of available treatments. The main [...]ver notícia -
Ancestry and genetic variants influence the risk of colorectal cancer
Publicado em 05 setembro 2025One of the largest Brazilian studies on colorectal cancer has revealed how genetic variations and genetic ancestry can influence the risk of developing the disease. The study, conducted by researchers at Hospital de Amor (formerly Hospital de Câncer de Barretos, in the interior of the state of São Paulo) and other institutions and funded by FAPESP, contributes to understanding the complex genetic reality of a highly mixed population such as Brazil’s. It was published in [...]ver notícia